Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial.

[1]  D. Jewell,et al.  A Comparison of Budesonide and Mesalamine for Active Crohn's Disease , 1998 .

[2]  M. Cottone,et al.  Mesalamine in the maintenance treatment of Crohn's disease: a meta-analysis adjusted for confounding variables. , 1997, Gastroenterology.

[3]  D. Jewell,et al.  A randomized, double-blind, placebo-controlled trial of olsalazine for active Crohn's disease. , 1995 .

[4]  U. Klotz,et al.  Delivery and fate of oral mesalamine microgranules within the human small intestine. , 1995, Gastroenterology.

[5]  D. Jewell,et al.  A Randomized, Double‐Blind, Placebo‐Controlled Trial of Olsalazine for Active Crohn's Disease , 1995, Inflammatory bowel diseases.

[6]  A. Zinsmeister,et al.  A randomized, double-blind, placebo-controlled trial of the oral mesalamine (5-ASA) preparation, Asacol, in the treatment of symptomatic Crohn's colitis and ileocolitis. , 1994, Journal of clinical gastroenterology.

[7]  D. Jewell,et al.  A comparison of budesonide with prednisolone for active Crohn's disease. , 1994, The New England journal of medicine.

[8]  J. Singleton.  Second trial of mesalamine therapy in the treatment of active Crohn's disease. , 1994, Gastroenterology.

[9]  C. Prantera,et al.  Oral 5-Aminosalicylic Acid (Asacol) in the Maintenance Treatment of Crohnʼs Disease , 1993 .

[10]  S. Hanauer,et al.  Mesalamine capsules for the treatment of active Crohn's disease: results of a 16-week trial. Pentasa Crohn's Disease Study Group. , 1993, Gastroenterology.

[11]  M. De Vos,et al.  Concentrations of 5-ASA and Ac-5-ASA in human ileocolonic biopsy homogenates after oral 5-ASA preparations. , 1992, Gut.

[12]  G. Koch,et al.  The Application of the Principle of Intention–to–Treat to the Analysis of Clinical Trials , 1991 .

[13]  Coated oral 5‐aminosalicylic acid versus placebo in maintaining remission of inactive Crohn's disease , 1990, Alimentary Pharmacology and Therapeutics.

[14]  J. Schölmerich,et al.  Oral 5-Aminosalicyclic Acid Versus 6-Methylprednisolone in Active Crohn's Disease , 1990 .

[15]  I. Beck,et al.  Oral 5-ASA Versus Prednisone in Short Term Treatment of Crohn's Disease: A Multicentre Controlled Trial , 1990 .

[16]  P. Gionchetti,et al.  5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? , 1988, Journal of clinical gastroenterology.

[17]  J. Rask-Madsen,et al.  5-Aminosalicylic acid in the treatment of Crohn's disease. A 16-week double-blind, placebo-controlled, multicentre study with Pentasa. , 1987, Scandinavian journal of gastroenterology.

[18]  L. Sutherland,et al.  5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. , 1987, Gastroenterology.

[19]  R. Farmer,et al.  Long-term follow-up of patients with Crohn's disease. Relationship between the clinical pattern and prognosis. , 1985, Gastroenterology.

[20]  K. Ewe,et al.  European cooperative Crohn's disease study (ECCDS) : Results of drug treatment , 1984 .

[21]  J. V. van Tongeren,et al.  Effect of sulphapyridine, 5-aminosalicylic acid, and placebo in patients with idiopathic proctitis: a study to determine the active therapeutic moiety of sulphasalazine. , 1980, Gut.

[22]  R. Summers,et al.  National Cooperative Crohn's Disease Study: results of drug treatment. , 1979, Gastroenterology.

[23]  F Kern,et al.  Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. , 1976, Gastroenterology.

[24]  E. Galper,et al.  [Crohn's disease]. , 1969, Hospital.